Pre-B Cell Colony Enhancing Factor (PBEF), a Cytokine with Multiple Physiological Functions

Overview

Journal Cytokine Growth Factor Rev

Date 2013 Jun 22

PMID 23787158

Citations 45

Authors

Zhongjie Sun

Han Lei

Zhonge Zhang

Affiliations

Soon will be listed here.

Abstract

Pre-B cell colony enhancing factor (PBEF) is regarded as a proinflammatory cytokine. Named for its first discovered function as a pre-B cell colony enhancing factor, it has since been found to have many other functions relating to cell metabolism, inflammation, and immune modulation. It has also been found to have intracellular and extracellular forms, with the two overlapping in function. Most of the intracellular functions of PBEF are due to its role as a nicotinamide phosphoribosyltransferase (Nampt). It has been found in human endothelial cells, where it is able to induce angiogenesis through upregulation of VEGF and VEGFR and secretion of MCP-1. In human umbilical endothelial cells, PBEF increases levels of the protease MMP 2/9. PBEF has also been found in a variety of immune cells other than B cells and has been shown to inhibit apoptosis of macrophages. Extracellular PBEF has been shown to increase inflammatory cytokines, such as TNF-α, IL-1β, IL-16, and TGF-β1, and the chemokine receptor CCR3. PBEF also increases the production of IL-6, TNF-α, and IL-1β in CD14(+) monocyctes, macrophages, and dendritic cells, enhances the effectiveness of T cells, and is vital to the development of both B and T lymphocytes. The purpose of this review is to summarize the recent advances in PBEF research.

Citing Articles

The adipokines in oral cancer pathogenesis and its potential as a new therapeutic approach.

Wang X, Wang J, Zhao X, Zhang J, Zhang Y Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40056203 DOI: 10.1007/s00210-025-03939-w.

The function of nicotinamide phosphoribosyl transferase (NAMPT) and its role in diseases.

Peng A, Li J, Xing J, Yao Y, Niu X, Zhang K Front Mol Biosci. 2024; 11:1480617.

PMID: 39513038 PMC: 11540786. DOI: 10.3389/fmolb.2024.1480617.

Comparative Effects of and Berberine on Adipokines, Body Composition, and Metabolic Parameters in Obese Patients: A Randomized Study.

Bandala C, Carro-Rodriguez J, Cardenas-Rodriguez N, Pena-Montero I, Gomez-Lopez M, Hernandez-Roldan A Nutrients. 2024; 16(14).

PMID: 39064727 PMC: 11280467. DOI: 10.3390/nu16142284.

NAMPT‑NAD is involved in the senescence‑delaying effects of saffron in aging mice.

Xiao L, Sun R, Han Y, Xia L, Lin K, Fu W Exp Ther Med. 2024; 27(3):123.

PMID: 38410190 PMC: 10895469. DOI: 10.3892/etm.2024.12411.

Adipokines in Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets.

Bilski J, Schramm-Luc A, Szczepanik M, Mazur-Bialy A, Bonior J, Luc K Biomedicines. 2023; 11(11).

PMID: 38001998 PMC: 10669400. DOI: 10.3390/biomedicines11112998.

References

Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M . Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol. 2005; 185(3):R1-8. DOI: 10.1677/joe.1.06211. View

Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K . Retraction. Science. 2007; 318(5850):565. DOI: 10.1126/science.318.5850.565b. View

Dzielak D . The immune system and hypertension. Hypertension. 1992; 19(1 Suppl):I36-44. DOI: 10.1161/01.hyp.19.1_suppl.i36. View

Chen H, Xia T, Zhou L, Chen X, Gan L, Yao W . Gene organization, alternate splicing and expression pattern of porcine visfatin gene. Domest Anim Endocrinol. 2006; 32(3):235-45. DOI: 10.1016/j.domaniend.2006.03.004. View

Lerner F, Niere M, Ludwig A, Ziegler M . Structural and functional characterization of human NAD kinase. Biochem Biophys Res Commun. 2001; 288(1):69-74. DOI: 10.1006/bbrc.2001.5735. View

Lopez-Bermejo A, Chico-Julia B, Fernandez-Balsells M, Recasens M, Esteve E, Casamitjana R . Serum visfatin increases with progressive beta-cell deterioration. Diabetes. 2006; 55(10):2871-5. DOI: 10.2337/db06-0259. View

Koczan D, Guthke R, Thiesen H, Ibrahim S, Kundt G, Krentz H . Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol. 2005; 15(4):251-7. View

Sheppard F, Kelher M, Moore E, McLaughlin N, Banerjee A, Silliman C . Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J Leukoc Biol. 2005; 78(5):1025-42. DOI: 10.1189/jlb.0804442. View

Benveniste E, Nguyen V, Wesemann D . Molecular regulation of CD40 gene expression in macrophages and microglia. Brain Behav Immun. 2003; 18(1):7-12. DOI: 10.1016/j.bbi.2003.09.001. View

10.

McHeyzer-Williams L, McHeyzer-Williams M . Antigen-specific memory B cell development. Annu Rev Immunol. 2005; 23:487-513. DOI: 10.1146/annurev.immunol.23.021704.115732. View

11.

Jonker M, Ossevoort And M, Vierboom M . Blocking the CD80 and CD86 costimulation molecules: lessons to be learned from animal models. Transplantation. 2002; 73(1 Suppl):S23-6. DOI: 10.1097/00007890-200201151-00009. View

12.

Adya R, Tan B, Punn A, Chen J, Randeva H . Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc Res. 2007; 78(2):356-65. DOI: 10.1093/cvr/cvm111. View

13.

Tokunaga A, Miura A, Okauchi Y, Segawa K, Fukuhara A, Okita K . The -1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects. Endocr J. 2008; 55(1):205-12. DOI: 10.1507/endocrj.k07e-039. View

14.

Rongvaux A, Galli M, Denanglaire S, Van Gool F, Dreze P, Szpirer C . Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress. J Immunol. 2008; 181(7):4685-95. DOI: 10.4049/jimmunol.181.7.4685. View

15.

Benson V, McMahon A, Lowe H . ICAM-1 in acute myocardial infarction: a potential therapeutic target. Curr Mol Med. 2007; 7(2):219-27. DOI: 10.2174/156652407780059131. View

16.

Xie H, Tang S, Luo X, Huang J, Cui R, Yuan L . Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int. 2007; 80(3):201-10. DOI: 10.1007/s00223-006-0155-7. View

17.

Mosser D, Zhang X . Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2009; 226:205-18. PMC: 2724982. DOI: 10.1111/j.1600-065X.2008.00706.x. View

18.

Adya R, Tan B, Chen J, Randeva H . Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis. Atherosclerosis. 2009; 205(1):113-9. DOI: 10.1016/j.atherosclerosis.2008.11.024. View

19.

Krzysik-Walker S, Ocon-Grove O, Maddineni S, Hendricks 3rd G, Ramachandran R . Is visfatin an adipokine or myokine? Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinology. 2007; 149(4):1543-50. DOI: 10.1210/en.2007-1301. View

20.

Dahl T, Yndestad A, Skjelland M, Oie E, Dahl A, Michelsen A . Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation. 2007; 115(8):972-80. DOI: 10.1161/CIRCULATIONAHA.106.665893. View